产后2天与4-12周糖耐量试验对妊娠期糖尿病女性的诊断价值比较
本研究前瞻性纳入300例妊娠期糖尿病产后女性,比较产后2天与4-12周糖耐量试验对1年后糖代谢异常的预测价值。结果显示两组在预测1年后糖化血红蛋白≥5.7%和≥6.5%的敏感度、特异度、阳性预测值及阴性预测值上均无显著差异,ROC曲线也相似,且产后2天完成率近100%。
要点
- 产后2天糖耐量试验在预测1年后糖代谢异常方面与4-12周试验诊断价值相似。
- 产后2天糖耐量试验完成率高达99%,显著高于4-12周试验的68%回访率。
- 可考虑将妊娠期糖尿病产后糖耐量试验时机提前至产后2天以提高依从性。
核心结论
- 产后2天糖耐量试验与4-12周糖耐量试验在预测1年后糖代谢异常和糖尿病方面具有相似的诊断价值,且产后2天试验依从性接近100%。
研究设计与样本
- 前瞻性队列研究,纳入2017年1月至2018年7月在一家医院分娩的300例妊娠期糖尿病产后女性,均接受产后2天75克2小时糖耐量试验,并鼓励在产后4-12周复查糖耐量试验及1年后测定糖化血红蛋白。
主要发现
- 203例(68%)女性在产后约1年测定了糖化血红蛋白,其中35%存在糖代谢异常(糖化血红蛋白≥5.7%),4%存在糖尿病(糖化血红蛋白≥6.5%)。
- 产后2天与4-12周糖耐量试验预测1年后糖化血红蛋白≥5.7%的敏感度分别为46%和36%,特异度分别为79%和84%,阳性预测值分别为52%和53%,阴性预测值分别为75%和72%,差异均无统计学意义。
- 两种糖耐量试验在识别1年后糖尿病方面也无差异,且ROC曲线相似。
关键数值与推荐
- 异常的产后2天糖耐量试验定义为空腹血糖≥100 mg/dL或2小时血糖≥140 mg/dL。
- 糖代谢异常定义为糖化血红蛋白≥5.7%,糖尿病定义为糖化血红蛋白≥6.5%。
临床怎么用
- 对于妊娠期糖尿病产后女性,可考虑将糖耐量试验提前至产后2天进行,以大幅提高筛查完成率,且其预测1年后糖代谢异常的价值与常规4-12周试验相当。
局限性
- 研究为单中心设计,4-12周糖耐量试验回访率仅68%,1年糖化血红蛋白测定率也为68%,可能存在失访偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A majority of women in the United States with gestational diabetes mellitus do not undergo the recommended 4- to 12-week postpartum glucose tolerance test. OBJECTIVE: This study aimed to compare the diagnostic value of the 2-day postpartum glucose tolerance test with the 4- to 12-week postpartum glucose tolerance test to identify impaired glucose metabolism at 1 year after delivery among women with gestational diabetes. STUDY DESIGN: Postpartum women who delivered at 1 hospital between January 2017 and July 2018 were offered enrollment in a prospective cohort if they had gestational diabetes mellitus diagnosed by Carpenter-Coustan criteria or a 1-hour glucose challenge test result of ≥200 mg/dL, spoke English or Spanish, and planned to remain in the hospital for at least 2 days after delivery. Participating women underwent a 75-gram 2-hour glucose tolerance test on postpartum day 2 and were incentivized to have a 4- to 12-week glucose tolerance test and measurement of glycosylated hemoglobin at 1 year after delivery. Participants and providers were blinded to the 2-day postpartum results. The diagnostic value of an abnormal 2-day postpartum glucose tolerance test (fasting result of ≥100 mg/dL or 2-hour glucose tolerance test result of ≥140 mg/dL) was compared with that of an abnormal 4- to 12-week glucose tolerance test to identify impaired glucose metabolism (≥5.7% glycosylated hemoglobin) and diabetes (≥6.5% glycosylated hemoglobin) at 1 year after delivery. Receiver operating characteristic (ROC) curves were also compared at 2 days and 4-12 weeks after delivery. RESULTS: Of the 300 recruited women, 296 (99%) completed the 2-day postpartum glucose tolerance test, and 202 (68%) returned for the 4- to 12-week glucose tolerance test. Approximately 1 year after delivery, 203 (68%) women had their glycosylated hemoglobin measured, of whom 35% had impaired glucose metabolism and 4% had diabetes. The study population was diverse (46% nonwhite). Furthermore, 56% were obese (mean body mass index, 32 kg/m2), and 55% had received medication to control their glucose during pregnancy. There were no significant differences between the 2-day and 4- to 12-week postpartum glucose tolerance tests in predicting impaired glucose metabolism based on ≥5.7% glycosylated hemoglobin in 1 year after delivery: sensitivity (46% vs 36%); specificity (79% vs 84%); positive predictive value (52% vs 53%); and negative predictive value (75% vs 72%). There was also no difference between the 2-day and the 4- to 12-week glucose tolerance tests in identifying diabetes at 1 year after delivery. Both the 2-day and 4- to 12-week glucose tolerance tests had similar ROC curves in identifying impaired glucose metabolism and diabetes at 1 year after delivery. CONCLUSION: Two-day postpartum glucose tolerance tests have similar diagnostic value as 4- to 12-week postpartum glucose tolerance tests in predicting impaired glucose metabolism and diabetes at 1 year after delivery and are associated with nearly 100% adherence to the test. Thus, changing the timing of the glucose tolerance test should be considered.
引用
- Werner EF, Has P, Rouse D, et al. Two-day postpartum compared with 4- to 12-week postpartum glucose tolerance testing for women with gestational diabetes. Am J Obstet Gynecol. 2020. PMID: 32470456. doi:10.1016/j.ajog.2020.05.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。